Dx Deals: Quest Makes Big North American Expansion with LifeLabs Acquisition
The roughly $1 billion deal will boost the company’s annual revenue by about 7 percent, and will give Quest a stronger presence in Canada.
The roughly $1 billion deal will boost the company’s annual revenue by about 7 percent, and will give Quest a stronger presence in Canada.
From - Laboratory Industry Report
After a relatively slow March and April, business has picked up noticeably in May, June and July with deal volume increasing across all…
From - Laboratory Industry Report
Deal volume in May and June was noticeably higher, especially in terms of M&A activity. There was more global activity over the current than…
From - Laboratory Industry Report
The big story of April wasn't any particular new deal but the apparent resolution of an old one—the Abbott-Alere merger. Deal volume remained…
From - Laboratory Industry Report
Although several companies secured favorable diagnostic coverage determinations in March, the big winner was Vermillion, manufacturer of the…
From - Laboratory Industry Report
In the early months of 2017, the diagnostic industry has seen several strategic alliances develop.
Among the most active companies…
From - Laboratory Industry Report
During a slow month for diagnostic M&A activity, a noteworthy deal was the closing of Grifols's acquisition of Hologic's blood screening business. The acquired assets include…
From - Laboratory Industry Report
Veracyte, Inc. is a leader in developing noninvasive genomic diagnostic tests for lung cancer. And in February, Veracyte's share of this lucrative market grew…